| CAS NO: | 2357111-29-4 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | Thalidomide-Piperazine-PEG1-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide basedcereblonligand and a linker used inPROTACtechnology[1]. | ||||||||||||||||
| IC50& Target |
| ||||||||||||||||
| 体外研究 (In Vitro) | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. | ||||||||||||||||
| 分子量 | 429.47 | ||||||||||||||||
| Formula | C21H27N5O5 | ||||||||||||||||
| CAS 号 | 2357111-29-4 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. | ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 250 mg/mL(582.11 mM;Need ultrasonic) 配制储备液
|
m.cnreagent.com